Gornoslaskie Centrum Zdrowia Dziecka Im. Sw. Jana Pawla II Samodzielny Publiczny Szpital Kliniczny Nr 6 Slaskiego Uniwersytetu Medycznego W Katowicach — Clinical Trial Site

15 Registered trials

11 Currently recruiting

Organisation

Gornoslaskie Centrum Zdrowia Dziecka Im. Sw. Jana Pawla II Samodzielny Publiczny Szpital Kliniczny Nr 6 Slaskiego Uniwersytetu Medycznego W Katowicach

Location

Katowice, Poland

Identifier

ORG-100046436

Address

Ul. Medykow 16, 40-752, Poland

Departments

Dep. Of Oncology, Hematology and Chemotherapy
Department of Oncology, Hematology and Chemotherapy
Dept of Pediatric Oncology, Hematology and Chemotherapy
Górnośląskie Centrum Zdrowia Dziecka im. Św. Jana Pawła II Samodzielny Publiczny Szpital Kliniczny
Oddzial Diabetologii Dzieciecej i Pediatrii
Oddział Diabetologii Dziecięcej i Pediatrii Katedra Pediatrii WNMK
Oddział Gastroenterologiczny
Oddział Kardiologii Dziecięcej
Oddział Onkologii, Hematologii i Chemioterapii
Oddział Onkologii, Hematologii i Chemioterapii, Klinika Pediatrii
Oddział Pediatrii i Neurologii Wieku Rozwojowego
Poradnia Diabetologiczna

Clinical trials at this site (15)

Search interface

Ublituximab in Pediatric Participants with Relapsing forms of Multiple Sclerosis (RMS) Recruiting

2025-522257-19-00 Relapsing Multiple Sclerosis 10 2026-05-12
A study to learn more about how safe finerenone is, when it is taken for a longer time with standard treatment, in children and young adults… Recruiting

2024-519830-22-00 Heart failure due to systemic left ventricular systolic 5 2026-04-27
Treatment of infants under one year with acute lymphoblastic leukemia according to the Interfant-21 protocol Recruiting

2022-502503-30-00 Acute lymphoblastic leukemia 5 2022-12-15
A study to learn more about how well finerenone works, how safe it is, and how it moves into, through, and out of the body compared to place… Recruiting

2024-519829-38-00 Heart failure due to systemic left ventricular systolic 5 2026-01-09
A multicenter, randomized, blinded, placebo controlled, phase II study to evaluate the safety and efficacy of cell therapy based with artifi… Recruiting

2023-505226-33-00 Presymptomatic diabetes type 1 (stage 1) 4 2025-01-28
Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with … Recruiting

2024-518316-39-00 Acute lymphoblastic leukemia 10 2024-11-18
Frexalimab in preservation of endogenous insulin secretion compared to placebo in adults, adolescents and children on top of Insulin therapy… Recruiting

2022-500531-36-00 Type 1 diabetes mellitus 4 2024-02-02
International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Recruiting

2022-500783-35-00 Acute Myeloid Leukemia 5 2022-12-06
A study of Vedulizumab in Children and Teenagers with Moderate to Severe Crohn's Disease (CD) Recruiting

2023-509045-13-00 Moderately to severely active Crohn's disease (CD) 5 2022-02-28
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
Paediatric Hepatic International Tumour Trial Recruiting

2024-516110-38-00 Hepatoblastoma and Hepatocellular Carcinoma 5 2018-03-06
STEP TEENS Weight Maintenance: A research study on how well semaglutide helps teenagers with excess body weight to lose weight and maintain … Ended

2023-508055-40-00 Obesity 6 2025-02-18
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018 Ended

2022-501457-37-00 Myeloid Leukemia in Children with Down Syndrome 5 2024-10-28
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended

2024-517253-27-00 Acute lymphoblastic leukemia 5 2021-07-01
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) Ended

2023-509018-12-00 Moderately to severely active Ulcerative Colitis (UC) 5 2021-12-17